Expression of cDNA encoding the human “protective protein≓ associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases
Abstract
The "protective protein" is a glycoprotein that associates with lysosomal beta-galactosidase and neuraminidase and is deficient in the autosomal recessive disorder galactosialidosis. We have isolated the cDNA encoding human "protective protein". The clone recognizes a 2 kb mRNA in normal cells that is not evident in fibroblasts of an early infantile galactosialidosis patient. The cDNA directs the synthesis of a 452 amino acid precursor molecule that is processed in vivo to yield mature "protective protein," a heterodimer of 32 kd and 20 kd polypeptides held together by disulfide bridges. This mature form is also biologically functional since it restores beta-galactosidase and neuraminidase activities in galactosialidosis cells. The predicted amino acid sequence of the "protective protein" bears homology to yeast carboxypeptidase Y and the KEX1 gene product. This suggests a protease activity for the "protective protein."
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A small pool of phosphorylated PPCA precursor can be recovered extracellularly, but this secreted form can be re-internalized via mannose-6-phosphate receptor-mediated endocytosis and routed to lysosomes where it becomes catalytically active.
“A small pool of phosphorylated precursor can also be recovered extracellularly, but this secreted form can be re-internalized by cells via mannose-6-phosphate receptor-mediated endocytosis and routed to the lysosomes where it becomes catalytically active as the de novo synthesized enzyme 5,6.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [6]
In the absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching lysosomes is rapidly degraded; formation of the PPCA/NEU1/β-GAL complex has a reciprocal advantage for the three enzymes, which acquire active and stable conformation in lysosomes.
“In absence of functional PPCA, NEU1 is retained in the endosomal compartment while the pool of β-GAL reaching the lysosomes is rapidly degraded 36.”
From Galactosialidosis: historic aspects and overview of investigated and emerging treatment options (2017) · cites this paper as [6]
NEU1 requires an accessory protein for activity-the protective protein cathepsin A (CTSA; PPCA).
“NEU1 is unique among all known mammalian, microbial, or viral sialidases, as it requires an accessory protein for activity—the protective protein cathepsin A (CTSA; PPCA) (12, 19–23).”
From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [19]
NEU1 is unique among all known sialidases in that it requires an accessory protein for activity.
“NEU1 is unique among all known mammalian, microbial, or viral sialidases, as it requires an accessory protein for activity—the protective protein cathepsin A (CTSA; PPCA) (12, 19–23).”
From Structure of the immunoregulatory sialidase NEU1 (2023) · cites this paper as [19]
Cited by
Sorted by citations
Fisher, K. J., & Aronson, N. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99071-x · Cited by 52 · see citing works
Galactosialidosis: historic aspects and overview of investigated and emerging treatment options
Annunziata, I., & d’Azzo, A. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1266933 · Cited by 50 · see citing works
Self-citationStructure of the immunoregulatory sialidase NEU1
Gorelik, A., Illes, K., Mazhab-Jafari, M. T., & Nagar, B. (2023) · Science Advances · doi:10.1126/sciadv.adf8169 · Cited by 36 · see citing works
Hermo, L., Korah, N., Gregory, M., Liu, L. Y., Cyr, D. G., D'Azzo, A., & Smith, C. E. (2007) · Journal of Andrology · doi:10.2164/jandrol.107.002980 · Cited by 27 · see citing works
Self-citation
- Authors
- Galjart, N. J., Gillemans, N., Harris, A., van der Horst, G. T. J., Verheijen, F. W., Galjaard, H., & d'Azzo, A.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Institute for Medical Research (GB)
- ORCID
- Galjart, Niels J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1988-09
- Volume
- 54
- Issue
- 6
- Pages
- 755-764
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2024118722
- Cited by
- 220
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 2 · 2014: 4 · 2013: 6 · 2012: 6
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Università degli Studi di Napoli Federico II
- Topics
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- protective proteins, lysosomal beta-galactosidase, neuraminidase, galactosialidosis, cDNA cloning, proteolytic activity, carboxypeptidase Y, disulfide-linked heterodimer, precursor processing, lysosomal storage disease, glycoproteins
- MeSH terms
- Amino Acid Sequence, Base Sequence, beta-Galactosidase, Carbohydrate Metabolism, Inborn Errors, Carboxypeptidases, Cloning, Molecular, DNA, Galactosidases, Gene Expression Regulation, Glycoproteins, Humans, Lysosomes, Molecular Sequence Data, Neuraminidase, Nucleic Acid Hybridization, Peptide Hydrolases, Protein Binding, RNA, Messenger, Cathepsin A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review